Research & Innovation
News Overview
July 10, 2008
Overcoming boundaries:
Geri Winkler becomes the first diabetic to conquer the Seven Summits
Adventurer reaches the peak of Mount McKinley (Denali) in Alaska » more
Geri Winkler becomes the first diabetic to conquer the Seven Summits
Adventurer reaches the peak of Mount McKinley (Denali) in Alaska » more
June 27, 2008
Bayer at a glance:
New edition of “Names, Figures, Facts”
Service line for free booklet » more
New edition of “Names, Figures, Facts”
Service line for free booklet » more
June 23, 2008
New Bayer technology reduces power consumption and CO2 emissions by 30 percent:
Bayer receives Environmental Award from the Federation of German Industries
Energy-efficient process recycles chlorine from hydrochloric acid / Industrial application in Germany and China / Bayer Management Board member Dr. Plischke: “Increase in energy efficiency brings economic and ecological benefits” » more
1:49 min.
Bayer receives Environmental Award from the Federation of German Industries
Energy-efficient process recycles chlorine from hydrochloric acid / Industrial application in Germany and China / Bayer Management Board member Dr. Plischke: “Increase in energy efficiency brings economic and ecological benefits” » more
June 16, 2008
Pilot plant for future-oriented technology opens in Halle:
Bayer will use tobacco plants to produce medicines
First development candidate from the new plant for cancer indication non-Hodgkin’s lymphoma – Clinical phase I could start in 2009 / Bayer has invested over EUR 10 million in Halle since 2006 » more
1:29 min.
Bayer will use tobacco plants to produce medicines
First development candidate from the new plant for cancer indication non-Hodgkin’s lymphoma – Clinical phase I could start in 2009 / Bayer has invested over EUR 10 million in Halle since 2006 » more
June 16, 2008
Inauguration of Bayer’s pilot facility for the “production of medicinal products in tobacco plants”
Halle, Germany
Address by Dr. Wolfgang Plischke
Member of the Management Board of Bayer AG » more
Address by Dr. Wolfgang Plischke
Member of the Management Board of Bayer AG » more
June 16, 2008
Inauguration of Bayer’s pilot facility for the “production of medicinal products in tobacco plants”
Halle, Germany
Address by Prof. Dr. Yuri Gleba
Managing Director of Icon Genetics AG » more
Address by Prof. Dr. Yuri Gleba
Managing Director of Icon Genetics AG » more
June 16, 2008
Bayer CropScience opens rice research laboratory in Singapore
Investment of EUR 5 million to support development of new rice varieties for the Asian market » more
Investment of EUR 5 million to support development of new rice varieties for the Asian market » more
May 30, 2008
Prevention of Thromboembolism after Knee Replacement Surgery:
Rivaroxaban One Tablet/Once-Daily Superior to Twice-Daily Injectable Enoxaparin in Preventing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Rivaroxaban is First Oral Anticoagulant to Achieve Superior Efficacy over the Twice-Daily Injection of Enoxaparin while Maintaining Low Major Bleeding Rates / RECORD4 Confirms Results of RECORD1, 2 and 3 / U.S. Submission Planned for mid 2008 / Prof. Turpie: “Rivaroxaban has the potential to revolutionize the way we prevent the formation of dangerous blood clots” » more
1:46 min.
Rivaroxaban One Tablet/Once-Daily Superior to Twice-Daily Injectable Enoxaparin in Preventing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Rivaroxaban is First Oral Anticoagulant to Achieve Superior Efficacy over the Twice-Daily Injection of Enoxaparin while Maintaining Low Major Bleeding Rates / RECORD4 Confirms Results of RECORD1, 2 and 3 / U.S. Submission Planned for mid 2008 / Prof. Turpie: “Rivaroxaban has the potential to revolutionize the way we prevent the formation of dangerous blood clots” » more
May 19, 2008
Amikacin Inhale shows promising results in Phase II Study
Bayer together with Nektar Therapeutics present preliminary Phase II data for the adjunctive treatment of pneumonia in intubated and mechanically-ventilated patients » more
1:38 min.
Bayer together with Nektar Therapeutics present preliminary Phase II data for the adjunctive treatment of pneumonia in intubated and mechanically-ventilated patients » more
May 19, 2008
Bayer Climate Program
Bayer Climate Check certified by TÜV Süd
Innovative control instrument for climate-friendly production processes » more
Bayer Climate Check certified by TÜV Süd
Innovative control instrument for climate-friendly production processes » more
May 7, 2008
IFAT 2008
Wastewater treatment process "made by Bayer"
Bayer Technology Services presents proven environmental protection technologies at the leading international trade fair for the environmental sector. » more
Wastewater treatment process "made by Bayer"
Bayer Technology Services presents proven environmental protection technologies at the leading international trade fair for the environmental sector. » more
April 21, 2008
HANNOVER FAIR/INTERKAMA+
Bayer Technology Services presents innovative optimization and identification technologies
Operational Excellence can significantly enhance productivity / Complete range of identification technologies / Bayer Climate Check: Tool for the reduction of CO2 emissions » more
Bayer Technology Services presents innovative optimization and identification technologies
Operational Excellence can significantly enhance productivity / Complete range of identification technologies / Bayer Climate Check: Tool for the reduction of CO2 emissions » more
February 25, 2008
Bayer invests more than 7 million euros in research center in Aachen, Germany
Cooperation between Bayer MaterialScience, Bayer Technology Services, and RWTH Aachen » more
1:17 min.
Cooperation between Bayer MaterialScience, Bayer Technology Services, and RWTH Aachen » more
November 26, 2007
Bayer CropScience, Mertec and M.S. Technologies to co-develop new soybean trait products
Joint collaboration will bring alternative herbicide tolerant systems and more choice for farmers in weed management » more
Joint collaboration will bring alternative herbicide tolerant systems and more choice for farmers in weed management » more
October 24, 2007
Nano silver ink developed for ink jet printing:
Electrical wiring diagrams invisible to the naked eye
High conductivity and good adhesion at low curing temperatures / Great potential in the field of printed electronics » more
Electrical wiring diagrams invisible to the naked eye
High conductivity and good adhesion at low curing temperatures / Great potential in the field of printed electronics » more
October 24, 2007
Bayer MaterialScience presents “VisionWorks Award”
Young designers are shaping the future
Students develop ideas for state-of-the-art means of transportation » more
Young designers are shaping the future
Students develop ideas for state-of-the-art means of transportation » more
October 15, 2007
New top-line efficacy data presented from phase II trial of Alemtuzumab in multiple sclerosis:
Three-year analysis demonstrates continued robust treatment effect of Alemtuzumab compared to Rebif®
» more
Three-year analysis demonstrates continued robust treatment effect of Alemtuzumab compared to Rebif®
» more
October 9, 2007
New environmental regulations in Israel
Bayer Technology Services to build waste water facility in Israel
Expertise and experience the deciding factor » more
Bayer Technology Services to build waste water facility in Israel
Expertise and experience the deciding factor » more
October 8, 2007
Innovations at the Biotechnica 2007 in Hanover, Germany
Bayer Technology Services presents innovative solutions
Novel cell culture fermenter aeration, virus inactivation and online bioanalytics » more
Bayer Technology Services presents innovative solutions
Novel cell culture fermenter aeration, virus inactivation and online bioanalytics » more


Overview
Overview
more News
Bookmark this page
E-mail this page
All Bayer Science Podcasts


